2022 annual financial data
Jyong Biotech 2022 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -2,829,000 USD and net income was -6,630,000 USD.
Operating cash flow was -2,971,000 USD.
Get free Jyong Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -2,829,000 USD
- Net income
- -6,630,000 USD
- Operating cash flow
- -2,971,000 USD